Contact
Please use this form to send email to PR contact of this press release:
Athenex, Inc. Receives U.S. FDA Orphan Drug Designation for Oraxol for the Treatment of Angiosarcoma
TO:
Please use this form to send email to PR contact of this press release:
Athenex, Inc. Receives U.S. FDA Orphan Drug Designation for Oraxol for the Treatment of Angiosarcoma
TO: